FDA inspection at Meridian Trading Company in Boulder targets biological hazards Feb. 2

Melanie Keller, Deputy Commissioner for Operations and Chief Operating Officer of FDA
Melanie Keller, Deputy Commissioner for Operations and Chief Operating Officer of FDA
0Comments

The Food and Drug Administration (FDA) carried out an inspection at Meridian Trading Company in Boulder on Feb. 2, examining foodborne biological hazards, according to information available on the FDA’s website.

The resulting report noted that Meridian Trading Company was advised to voluntarily address issues related to organizational management operations.

The FDA regularly performs inspections nationwide to ensure products and facilities follow FDA regulations and laws designed to protect public health. Outcomes of those inspections are made publicly accessible.

The agency states on its website that it oversees the safety and quality of human and animal drugs, biological products, medical devices and tobacco products.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Caleb Michaud, Acting Associate Commissioner for External Affairs of FDA

FDA inspects Silver Canyon Coffee in Boulder for compliance on April 22

FDA records note an inspection at Silver Canyon Coffee in Boulder conducted on April 22, focusing on food composition, standards, labeling, economics, and biological hazards associated with foodborne illnesses.

Jim Traficant, Chief of Staff of FDA

FDA cites Silver Canyon Coffee in Boulder during April 22 inspection

The Food and Drug Administration conducted an inspection of Silver Canyon Coffee in Boulder on April 22, citing the business once for plant maintenance issues and reviewing food standards, labeling and biological hazards, based on information from the FDA’s official website.

Dr. Mehmet Oz CMS Administrator

Alcohol and drug abuse treatment Medicaid spending in Boulder surges to nearly $500,000 in 2024

Boulder saw Medicaid spending for Alcohol and Drug Abuse Treatment services jump by 91.7% to $499,954 in 2024, highlighting changing service use and payment trends in the city.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Boulder Leader.